Market Overview

Bristol-Myers Shares Fall 2.3% Over Last Min. As Traders Circulate Chatter Of Comment From Conference Call Suggesting Exec Said They Will Be Receiving Negative Opinion From CHMP for OPDIVO In Renal Cancer; Conference Call Just Recently Started At 10:30 a.m. EDT


This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Posted-In: News Rumors Movers Trading Ideas


Related Articles (BMY)

Intel Earnings Preview: High Expectations, Still No CEO

Sarepta's Clinical Hold Could Be A Solid Biosciences Catalyst, Says Bullish Chardan Analyst